NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in NextCure, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −13 vs. Q2 2025
- Shares held
- 858.1K
- −20.8K (−2.4%) vs. Q2 2025Converted for a 1-for-12 split
- Total value
- $5.03M
- −$620.7K (−11.0%) vs. Q2 2025
- New holders
- 0
- 3 more added
- Sold out
- 13
- 7 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | 222,654 | $1.30M | 0.08% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Affinity Asset Advisors, LLC | 191,882 | $1.12M | 0.10% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Pfizer Inc | 157,646 | $923.8K | 0.21% | +144,509+1,100.0% | AddedConverted for a 1-for-12 split |
| Vanguard Group Inc | 67,983 | $398.4K | 0.00% | −4,685−6.4% | ReducedConverted for a 1-for-12 split |
| Cable Car Capital LLC | 63,178 | $370.2K | 0.16% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Acadian Asset Management LLC | 36,675 | $213.0K | 0.00% | −4,028−9.9% | ReducedConverted for a 1-for-12 split |
| BlackRock, Inc. | 31,086 | $182.2K | 0.00% | −249−0.8% | ReducedConverted for a 1-for-12 split |
| Renaissance Technologies LLC | 28,334 | $166.0K | 0.00% | −13,411−32.1% | ReducedConverted for a 1-for-12 split |
| Cardiff Park Advisors, LLC | 21,833 | $127.9K | 0.01% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Geode Capital Management, LLC | 19,521 | $114.4K | 0.00% | +379+2.0% | AddedConverted for a 1-for-12 split |
| Sio Capital Management, LLC | 10,940 | $64.1K | 0.02% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Barclays PLC | 5,626 | $33.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| UBS Group AG | 601 | $3.52K | 0.00% | −424−41.4% | ReducedConverted for a 1-for-12 split |
| JPMorgan Chase & Co | 61 | $357 | 0.00% | −2−3.2% | ReducedConverted for a 1-for-12 split |
| BNP Paribas Arbitrage, SA | 32 | $188 | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Bank of America Corp | 23 | $134 | 0.00% | +0+1.1% | AddedConverted for a 1-for-12 split |
| Citigroup Inc | 1 | $6 | 0.00% | −85,455−100.0% | ReducedConverted for a 1-for-12 split |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −12,500−100.0% | Sold outConverted for a 1-for-12 split |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −9,834−100.0% | Sold outConverted for a 1-for-12 split |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −8,667−100.0% | Sold outConverted for a 1-for-12 split |
| State Street Corp | 0 | $0 | 0.00% | −5,449−100.0% | Sold outConverted for a 1-for-12 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,904−100.0% | Sold outConverted for a 1-for-12 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,958−100.0% | Sold outConverted for a 1-for-12 split |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −3,750−100.0% | Sold outConverted for a 1-for-12 split |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −3,112−100.0% | Sold outConverted for a 1-for-12 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,459−100.0% | Sold outConverted for a 1-for-12 split |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −1,438−100.0% | Sold outConverted for a 1-for-12 split |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −1,153−100.0% | Sold outConverted for a 1-for-12 split |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −127−100.0% | Sold outConverted for a 1-for-12 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold outConverted for a 1-for-12 split |